Search Research Articles
Browse Research Categories

Ovagen Peptide Research

Ovagen is a tripeptide bioregulator (Glu-Asp-Leu) derived from liver tissue, studied for its organ-specific regulatory effects on hepatocyte function and liver tissue homeostasis. Developed through the St. Petersburg Institute of Bioregulation and Gerontology’s bioregulator research program, Ovagen is investigated for its potential to normalize liver cell gene expression, support hepatic metabolic function, protect against toxic and age-related liver injury, and promote hepatic regeneration. Research has explored its applications in liver health maintenance, hepatoprotection, age-related hepatic decline, and as a complementary compound alongside other organ bioregulators. This section covers scientific studies on Ovagen and its liver health and organ-specific bioregulator peptide research applications.

Other Popular Research Categories

Newest Ovagen Research

Ovagen Peptide Research – Complete Guide

Ovagen is a synthetic tripeptide (Glu-Asp-Leu) developed by researchers at the Saint Petersburg Institute of Bioregulation and Gerontology and studied primarily for liver protection and gastrointestinal health in preclinical models. Unlike most bioactive peptides, Ovagen research focuses on direct nuclear interaction and chromatin remodeling rather than receptor-mediated signaling, placing it in a class of compounds called cytogene bioregulators with proposed...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0